1789 — AK Medical Holdings Income Statement
0.000.00%
Last trade - 00:00
- HK$6.79bn
- HK$6.12bn
- CNY1.09bn
- 69
- 19
- 20
- 24
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 927 | 1,035 | 761 | 1,052 | 1,094 |
Cost of Revenue | |||||
Gross Profit | 643 | 715 | 499 | 636 | 674 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 611 | 666 | 662 | 832 | 882 |
Operating Profit | 316 | 369 | 99.4 | 220 | 211 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 321 | 377 | 109 | 240 | 231 |
Provision for Income Taxes | |||||
Net Income After Taxes | 267 | 314 | 92.6 | 205 | 182 |
Net Income Before Extraordinary Items | |||||
Net Income | 267 | 314 | 92.6 | 205 | 182 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 267 | 314 | 92.6 | 205 | 182 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.252 | 0.29 | 0.083 | 0.197 | 0.163 |
Dividends per Share |